...
首页> 外文期刊>World neurosurgery >Preoperative charlson comorbidity score predicts postoperative outcomes among older intracranial meningioma patients.
【24h】

Preoperative charlson comorbidity score predicts postoperative outcomes among older intracranial meningioma patients.

机译:术前查尔森合并症评分可预测老年颅内脑膜瘤患者的术后预后。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Preoperative determinants of surgical risk in elderly patients with meningioma are not fully defined. This study was undertaken to determine whether the Charlson comorbidity index could be used to accurately predict postoperative outcomes among older patients with meningiomas undergoing neurosurgical resection and thereby make a selection for surgery easier. METHODS: We performed a multi-institutional retrospective cohort analysis via the Nationwide Inpatient Sample (1998-2005). Patients 65 years of age and older who underwent tumor resection of intracranial meningiomas were identified by International Classification of Diseases, 9th revision, coding. The primary independent variable in multivariate regression was the Charlson comorbidity score, and the primary outcome was inpatient death. Secondary outcomes included inpatient complications, length of stay, and total hospital charges. RESULTS: We identified 5717 patients (66.6% female, and 81.8% white) with mean age of 73.6 years. Mean Charlson comorbidity score was 0.99. Inpatient mortality was 3.2%. Mean length of stay was 9.1 days, and mean total charges were Dollars 62,983. In multivariate analysis, the only factors consistently associated with worse outcome were increased Charlson comorbidity score and increased patient age (ie, >65 years of age). Only greater Charlson scores were additionally associated with greater odds of all major complications such as neurological, respiratory, and cardiac complications. Elective procedures were consistently associated with less inpatient death, length of stay, and total charges. All associations were statistically significant (P < 0.05). CONCLUSIONS: The safe surgical resection of intracranial meningiomas among older patients is possible through the ninth decade of life. The Charlson comorbidity score has been shown to be a strong, consistent predictor of inpatient outcomes.
机译:目的:尚未确定老年脑膜瘤患者手术风险的术前决定因素。进行这项研究是为了确定Charlson合并症指数是否可用于准确预测接受神经外科手术切除的脑膜瘤老年患者的术后预后,从而使手术选择更加容易。方法:我们通过全国住院患者样本(1998-2005)进行了多机构回顾性队列分析。根据《国际疾病分类》(第9版)进行编码,确定接受颅内脑膜瘤肿瘤切除术的65岁及65岁以上患者。多元回归分析的主要独立变量为查尔森合并症评分,主要结果为住院死亡。次要结果包括住院并发症,住院时间和总住院费用。结果:我们确定了5717例患者(女性66.6%,白人81.8%),平均年龄为73.6岁。平均查尔森合并症评分为0.99。住院死亡率为3.2%。平均住院时间为9.1天,平均总费用为62,983美元。在多变量分析中,始终与较差结果相关的唯一因素是查尔森合并症评分增加和患者年龄增加(即,> 65岁)。另外,只有更高的Charlson评分与所有主要并发症(如神经系统,呼吸系统和心脏并发症)的几率更高。择期手术始终与住院患者死亡,住院时间和总费用减少相关。所有关联均具有统计学意义(P <0.05)。结论:在老年患者的第九个十年中,可以安全地手术切除老年患者的颅内脑膜瘤。查尔森合并症评分已被证明是住院结局的有力,一致的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号